Anandamide and 2-AG, the two best-studied signaling molecules in your body's endocannabinoid system, aren't pulled out of thin air. They're built from fat, specifically from fatty acids sitting in your cell membranes. That raises a fair question: if the raw material is fat, does which fats you actually eat change how much of this signaling is available? The research says yes, but with real limits on how simple that story is.
Omega-3s can become their own class of signaling molecules
Most people think of omega-3 fatty acids, found in fish and certain plant oils, purely in terms of general fat quality. But a 2018 study found that when omega-3s are converted into a related class of lipid called N-acylethanolamines, the resulting molecules preferentially activate CB2, one of the two main endocannabinoid receptors, without activating CB1. Interestingly, that same study found that several other abundant N-acylethanolamines, including palmitoylethanolamide, didn't activate either receptor, a reminder that being chemically similar to an endocannabinoid doesn't automatically mean a molecule acts like one. A 2017 study went a step further, showing that enzymes called cytochrome P450 epoxygenases convert the omega-3-derived endocannabinoids made from DHA and EPA into epoxide metabolites. In cell studies, those epoxide metabolites lowered the inflammatory signal IL-6 and raised the anti-inflammatory signal IL-10, and did so partly by activating CB2. This is a structural pathway, not a supplement claim: omega-3 fats appear to feed into endocannabinoid-adjacent signaling through a specific enzymatic conversion step, not just by being "healthy fat."
A controlled feeding trial that separates two questions people usually lump together
Here's where the honesty matters. A 2023 randomized, controlled 12-week feeding trial in 62 women with overweight tested whether simply lowering dietary linoleic acid, an omega-6 fat, would lower arachidonic acid or anandamide on its own. It did not. Cutting one input alone wasn't enough to move the needle. But when the same trial added EPA and DHA, the omega-3 fats, on top of that, the DHA-derived endocannabinoid rose by 35%. The lesson: it's not simply "less omega-6," it's specifically "more omega-3," that moved this particular signaling molecule. Removing a competing raw material and adding the preferred one are two different interventions, and only one of them worked here.
What happens at the other end of the diet spectrum
The flip side shows up in a 2023 mouse study looking at a diet high in linoleic acid, delivered as soybean oil. That diet lowered protective endocannabinoid-related compounds specifically in the intestine, shifted the composition of gut bacteria, and increased susceptibility to colitis in the animals. This doesn't mean any one oil is "bad," but it does show that the ratio of fats in a diet can shift endocannabinoid signaling in a specific tissue, the gut lining, with downstream effects on a structure that depends on that signaling to stay resilient.
Reading these four together
Line them up and a coherent, modest picture emerges: omega-3 fats can be converted into molecules that act on the same receptors as your body's own endocannabinoids, particularly CB2, and can measurably raise DHA-derived endocannabinoid levels when added to the diet. But this is a cofactor relationship, not a switch. Removing one fat without adding the other did nothing in the one controlled human trial that tested it directly. Diet is one input among several into this system, not the whole story. The other major input is what your body does with those raw materials once they've been converted into signaling molecules, and how quickly that signal gets built and cleared. And separately, how much of this signaling shows up on any given day depends heavily on what you did with your body that day, and how well you slept the night before.
Related reading
What builds and clears these molecules once the raw material is available, and why movement and sleep shift these same signaling molecules day to day, are the next two pieces of this system worth exploring. The underlying studies are also browsable, filtered to this mechanism.
Key Takeaways
- Anandamide and 2-AG, your body's own endocannabinoid signaling molecules, are built from fatty acids in cell membranes — so the type of fat you eat is a structural input, not just background nutrition.
- Omega-3 fats can be converted into their own class of signaling molecules that activate CB2 without activating CB1 — structural similarity to an endocannabinoid doesn't automatically mean a molecule acts like one.
- In a 12-week controlled trial, cutting omega-6 alone did not change endocannabinoid levels — adding EPA and DHA on top raised DHA-derived endocannabinoid levels by 35%. Removing one input and adding another are two different interventions.
- A diet high in linoleic acid (omega-6, from soybean oil) lowered protective endocannabinoid-related compounds in the gut lining in mice and shifted gut bacteria composition — the fat ratio in a diet can matter tissue by tissue.
- Diet is one input among several into this signaling system — not a switch, and not the whole story; enzyme activity, movement, and sleep all play their own separate roles.
Sources
Powered by CellWell.life- 1.n-3 polyunsaturated N-acylethanolamines are CB2 cannabinoid receptor-preferring endocannabinoids (2018)
- 2.Anti-inflammatory omega-3 endocannabinoid epoxides (2017)
- 3.Dietary linoleic acid lowering alone does not lower arachidonic acid or endocannabinoids among women with overweight and obesity: A randomized, controlled trial (2023)
- 4.Diet high in linoleic acid dysregulates the intestinal endocannabinoid system and increases susceptibility to colitis in Mice (2023)
Related